erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the
.
-
.
-
.
OFF DEAL
218 Used Today
OFF DEAL
181 Used Today
OFF DEAL
200 Used Today